Axogen (AXGN) Cash from Operations (2010 - 2026)
Axogen's (AXGN) quarterly Cash from Operations came in at 1565000.0 in Q1 2026, up 111.87% year-on-year from 738643.23 in Q1 2025, and down 48.49% quarter-over-quarter from 3038000.0 in Q4 2025.
Axogen (AXGN) Cash from Operations (2010 - 2026) Analysis & Trends
Axogen's Cash from Operations history runs 17 years deep, the most recent figure standing at 1565000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 111.87% year-over-year to 1565000.0 in Q1 2026; TTM through Mar 2026 was 15556000.0, a 329.49% increase from a year earlier, with the FY2025 full-year figure at 812000.0, down 82.09% from the prior year.
- Cash from Operations retreated to 1565000.0 in Q1 2026 per AXGN's latest filing, from 3038000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8735000.0 in Q4 2024 and bottomed at 13179000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 1362000.0 (2022), against an average of 874705.88.
- Across the five-year window, Cash from Operations slumped 718.42% in 2022 and surged 4239.81% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 1362000.0 in 2022, then sank by 115.49% to 211000.0 in 2023, then jumped by 4239.81% to 8735000.0 in 2024, then slumped by 65.22% to 3038000.0 in 2025, then slumped by 48.49% to 1565000.0 in 2026.
- Per Business Quant, the three latest AXGN Cash from Operations figures stand at 1565000.0 (Q1 2026), 3038000.0 (Q4 2025), and 3223000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 7.73 Mn |
| Jun 30, 2025 | 7.73 Mn |
| Mar 31, 2025 | -13.18 Mn |
| Mar 31, 2025 | -13.18 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | -12.27 Mn |
| Mar 31, 2024 | -12.27 Mn |
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |